Open Access
Open access
том 11 издание 4 страницы 951

rTMS Reduces Craving and Alcohol Use in Patients with Alcohol Use Disorder: Results of a Randomized, Sham-Controlled Clinical Trial

Maarten Belgers 1, 2
Philip van Eijndhoven 3
Wiebren Markus 1, 2
Aart Schene 3
Arnt F.A. Schellekens 3
Тип публикацииJournal Article
Дата публикации2022-02-11
scimago Q1
wos Q1
БС1
SJR0.919
CiteScore5.2
Impact factor2.9
ISSN20770383
General Medicine
Краткое описание

(1) Background: Current evidence-based treatments for alcohol use disorder (AUD) are moderately effective. Studies testing repetitive transcranial magnetic stimulation (rTMS) in AUD commonly apply a limited number of rTMS sessions with different rTMS settings, showing inconsistent effects on craving for alcohol. This study tested the efficacy of a robust rTMS protocol on craving and alcohol use. (2) Methods: In a single-blind randomized controlled trial in recently detoxified patients with AUD, ten days of high-frequency rTMS over the right dorsolateral prefrontal cortex on top of treatment as usual (n = 14) was compared with sham rTMS (n = 16). Outcome measures were alcohol craving and use over a follow-up period of one year. Analysis was performed by means of repeated measures multivariate analysis of variance. (3) Results: The results showed a main group-by-time interaction effect on craving (Wilks’ Λ = 0.348, F (12, 17) = 2.654, p = 0.032) and an effect of group on alcohol use (Wilk’s Λ = 0.44, F (6, 23) = 4.9, p = 0.002), with lower alcohol craving and use in the group with active rTMS compared to the control group. Differences in craving between groups were most prominent three months after treatment. At 12 months follow-up, there was no effect of rTMS on craving or abstinence. (4) Conclusions: This small-scale randomized controlled trial showed the efficacy of high-frequency rTMS over the right dlPFC diminished alcohol craving and use in recently detoxified patients with AUD during the first months after detoxification. These findings suggest that rTMS might be an effective add-on in treating patients with AUD and warrant replication in future large-scale studies.

Найдено 
Найдено 

Топ-30

Журналы

1
2
Neuropsychopharmacology
2 публикации, 7.69%
Neurology International
1 публикация, 3.85%
Addiction
1 публикация, 3.85%
Frontiers in Psychiatry
1 публикация, 3.85%
Psychoradiology
1 публикация, 3.85%
Neuroscience and Biobehavioral Reviews
1 публикация, 3.85%
Alcohol Clinical and Experimental Research
1 публикация, 3.85%
Egyptian Journal of Neurology, Psychiatry and Neurosurgery
1 публикация, 3.85%
Expert Review of Medical Devices
1 публикация, 3.85%
Developmental Cognitive Neuroscience
1 публикация, 3.85%
Journal of Addiction Medicine
1 публикация, 3.85%
Current Addiction Reports
1 публикация, 3.85%
Current Behavioral Neuroscience Reports
1 публикация, 3.85%
Advances in Clinical Medicine
1 публикация, 3.85%
Transcranial Magnetic Stimulation
1 публикация, 3.85%
Contemporary Clinical Trials Communications
1 публикация, 3.85%
PLoS ONE
1 публикация, 3.85%
Journal of Neuropsychiatry and Clinical Neurosciences
1 публикация, 3.85%
Journal of Addictive Diseases
1 публикация, 3.85%
Trials
1 публикация, 3.85%
Addiction Biology
1 публикация, 3.85%
Neurochemical Journal
1 публикация, 3.85%
1
2

Издатели

1
2
3
4
5
6
Springer Nature
6 публикаций, 23.08%
Elsevier
4 публикации, 15.38%
Wiley
3 публикации, 11.54%
Taylor & Francis
2 публикации, 7.69%
Cold Spring Harbor Laboratory
2 публикации, 7.69%
MDPI
1 публикация, 3.85%
Frontiers Media S.A.
1 публикация, 3.85%
Oxford University Press
1 публикация, 3.85%
Ovid Technologies (Wolters Kluwer Health)
1 публикация, 3.85%
Hans Publishers
1 публикация, 3.85%
Public Library of Science (PLoS)
1 публикация, 3.85%
American Psychiatric Association Publishing
1 публикация, 3.85%
Pleiades Publishing
1 публикация, 3.85%
1
2
3
4
5
6
  • Мы не учитываем публикации, у которых нет DOI.
  • Статистика публикаций обновляется еженедельно.

Вы ученый?

Создайте профиль, чтобы получать персональные рекомендации коллег, конференций и новых статей.
Метрики
27
Поделиться
Цитировать
ГОСТ |
Цитировать
Belgers M. et al. rTMS Reduces Craving and Alcohol Use in Patients with Alcohol Use Disorder: Results of a Randomized, Sham-Controlled Clinical Trial // Journal of Clinical Medicine. 2022. Vol. 11. No. 4. p. 951.
ГОСТ со всеми авторами (до 50) Скопировать
Belgers M., van Eijndhoven P., Markus W., Schene A., Schellekens A. F. rTMS Reduces Craving and Alcohol Use in Patients with Alcohol Use Disorder: Results of a Randomized, Sham-Controlled Clinical Trial // Journal of Clinical Medicine. 2022. Vol. 11. No. 4. p. 951.
RIS |
Цитировать
TY - JOUR
DO - 10.3390/jcm11040951
UR - https://doi.org/10.3390/jcm11040951
TI - rTMS Reduces Craving and Alcohol Use in Patients with Alcohol Use Disorder: Results of a Randomized, Sham-Controlled Clinical Trial
T2 - Journal of Clinical Medicine
AU - Belgers, Maarten
AU - van Eijndhoven, Philip
AU - Markus, Wiebren
AU - Schene, Aart
AU - Schellekens, Arnt F.A.
PY - 2022
DA - 2022/02/11
PB - MDPI
SP - 951
IS - 4
VL - 11
PMID - 35207224
SN - 2077-0383
ER -
BibTex |
Цитировать
BibTex (до 50 авторов) Скопировать
@article{2022_Belgers,
author = {Maarten Belgers and Philip van Eijndhoven and Wiebren Markus and Aart Schene and Arnt F.A. Schellekens},
title = {rTMS Reduces Craving and Alcohol Use in Patients with Alcohol Use Disorder: Results of a Randomized, Sham-Controlled Clinical Trial},
journal = {Journal of Clinical Medicine},
year = {2022},
volume = {11},
publisher = {MDPI},
month = {feb},
url = {https://doi.org/10.3390/jcm11040951},
number = {4},
pages = {951},
doi = {10.3390/jcm11040951}
}
MLA
Цитировать
Belgers, Maarten, et al. “rTMS Reduces Craving and Alcohol Use in Patients with Alcohol Use Disorder: Results of a Randomized, Sham-Controlled Clinical Trial.” Journal of Clinical Medicine, vol. 11, no. 4, Feb. 2022, p. 951. https://doi.org/10.3390/jcm11040951.
Профили